You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨康希諾生物大漲逾11% 股價再創上市以來新高
格隆匯 02-14 13:26
格隆匯2月14日丨康希諾生物(6185.HK)大漲 11%,報83.45港元,今年以來股價已近累漲逾40%,且刷新歷史新高,總市值186億港元。

康希諾生物近日公告稱,其科創板上市申請已獲得上交所受理。此次申請上市,康希諾擬申請公開發行不超過2480萬股,擬募集資金10億元,將用於生產基地二期建設、在研疫苗研發、疫苗追溯、冷鏈物流體系及信息系統建設以及補充流動資金之中。
此外,2月10日,中國疫苗行業協會官方微信發佈消息稱,截至目前有18家會員單位正在開展新冠肺炎疫苗的研製工作,康希諾生物亦位列其中。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account